VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1018364
Sex: M
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tiredness; headache; muscle pain; chills; injection site swelling; feeling unwell; swollen lymph nodes - Moderate-severe (Left axillary lymphadenopathy); injection site pain; This is a spontaneous report from a contactable physician (patient). A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection. lot number: EL3249), via an unspecified route of administration on 21Jan2021 at a single dose on left arm for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. No vaccines received 4 weeks prior to vaccination. The patient experienced injection site pain on 21Jan2021. On 22Jan2021 (24 hours after vaccination), patient experienced tiredness, headache, muscle pain, chills, injection site swelling, feeling unwell and swollen lymph nodes - moderate-severe (left axillary lymphadenopathy). All occurred for a duration of 24 hours, except for event swollen lymph nodes - Moderate-severe (Left axillary lymphadenopathy) in which reported duration was 48 + hours. The patient was treated with ibuprofen for the events. The patient was not tested for COVID-19 post vaccination. The patient has not recovered from the events.

Other Meds:

Current Illness:

ID: 1018365
Sex: F
Age:
State: IL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash on right side of neck; Rash of bumps on the left arm where injection happened; Rash of bumps on the left arm where injection happened; Some difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on left arm on 22Jan2021 13:30 at single dose for COVID-19 immunization. Medical history included asthma, allergies and migraine. Concomitant medication included ibuprofen, albuterol [salbutamol] and sumatriptan. The patient previously took clindamycin and experienced drug allergy. The patient experienced rash of bumps on the left arm where injection happened, rash on right side of neck some difficulty breathing on 22Jan2021 19:30. The patient received treatment Benadryl and albuterol to treat symptoms. The outcome of events was recovered in Jan2021. Information on the Lot/Batch number has been requested.

Other Meds: IBUPROFEN; ALBUTEROL [SALBUTAMOL]; SUMATRIPTAN

Current Illness:

ID: 1018366
Sex: M
Age:
State: VA

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: experiencing swelling in the armpit of the arm I was injected in; This is a spontaneous report from a contactable other healthcare professional, reporting for himself. A 56-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EJ1685, via an unspecified route of administration on 06Jan2021 at 15:30 (at the age of 56 years old) as a single dose in the right arm for COVID-19 vaccination. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included famotidine (Pepcid AC) for an unknown indication from unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination, but did receive the first dose of BNT162B2, lot number: EJ1685 on 16Dec2020 at 11:00 AM in the right arm. On 08Jan2021, the patient experienced swelling in the armpit of the arm he was injected in. The patient did not receive treatment for the event. The event did involve doctor or other healthcare professional office/clinic visit. The clinical outcome of swelling in the armpit of the arm he was injected in was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: Pepcid AC

Current Illness:

ID: 1018367
Sex: F
Age:
State: MD

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Light headedness; scratchy voice; itchy eyes and throat; itchy eyes and throat; pink and hot swollen circular hive/welt underneath injection site on left arm; pink and hot swollen circular hive/welt underneath injection site on left arm; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Jan2021 at 07:30 (at the age of 41 years old) as a single dose in the left arm for COVID-19 vaccination. Medical history included seasonal allergies from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination, but did receive the first dose of BNT162B2, on 31Dec2020 in the left arm. On 21Jan2021 at 09:30, the patient experienced light headedness, scratchy voice, itchy eyes and throat, pink and hot swollen circular hive/welt underneath injection site on left arm. The patient did not receive treatment for the events. The clinical outcome of light headedness, scratchy voice, itchy eyes and throat, pink and hot swollen circular hive/welt underneath injection site on left arm was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018368
Sex: M
Age:
State: UT

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Flu like symptoms; Headache; Body ache; Chills; General malaise; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number: EL 9261), via an unspecified route of administration in the left arm on 20Jan2021 at 11:15 (at the age of 74-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications were unknown. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 21Jan2021 at 04:00, the patient experienced Flu like symptoms that lasted about 8 hours, headache, body ache, chills, general malaise. The patient stated he had no fever. The patient did not receive any treatment for the event. The clinical outcome of the Flu like symptoms, headache, body ache, chills, and general malaise was recovered on an unknown date in Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1018369
Sex: F
Age:
State: FL

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Within 20 minute of receiving the shot my face was very flushed and hot; Within 20 minute of receiving the shot my face was very flushed and hot; lips slightly swollen; Mild itching on face continues 20 hours later; This is a spontaneous report from a contactable consumer reporting for herself. A 72-years-old non-pregnant female patient received BNT162B2 lot number unknown, via an unspecified route of administration on 22Jan2021 15:45 (at the age of 72-years-old) as a SINGLE DOSE in the right arm for covid-19 immunisation. Medical history was none. It was unknown if the patient had allergies to medications, food, or other products. Concomitant medications were none. The facility where the most recent COVID-19 vaccine was administered was provided as other. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Within 20 minutes of receiving the shot, the patient's face was very flushed and hot, lips slightly swollen on 22Jan2021 16:00. Mild itching on face from unspecified date in Jan2021 continues 20 hours later. No treatment was received for the events. The clinical outcome of within 20 minute of receiving the shot my face was very flushed and hot was not recovered It was also reported that since the vaccination, the patient had not been tested for COVID-19. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018370
Sex: F
Age:
State:

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: her eyes are watering, she can't quit sneezing; her eyes are watering, she can't quit sneezing; her nose drips hot water; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 22Jan2021 as a SINGLE DOSE for COVID-19 vaccination. Medical history included spinal cord injury 14 years ago (2007) to an unknown date. The patient's concomitant medications were not reported. The patient experienced her eyes are watering, she can't quit sneezing and her nose drips hot water on an unspecified date in Jan2021. The clinical outcomes of her eyes are watering, she can't quit sneezing and her nose drips hot water was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018371
Sex: F
Age:
State: VA

Vax Date: 01/18/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling in the area at the base of the neck on the left shoulder; swelling in the area at the base of the neck on the left shoulder, (there was a small lump in that area); Soreness/tenderness in the area near the collarbone; Soreness/tenderness in the area near the collarbone; Pain in the left armpit; Swollen lymph node; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ELI283 and expiry date: unknown), via an unspecified route of administration on the left arm, on 18Jan2021 12:15 at single dose for covid-19 immunisation. Medical history included high blood pressure and seasonal allergies. Patient was not pregnant at the time of vaccination. Concomitant medication included losartan potassium, naproxen sodium (ALEVE) and unspecified OTC allergy medications. There were no other vaccines received within 4 weeks prior to COVID vaccination. The patient experienced pain in the left armpit and swollen lymph node on 23Jan2021 11:30. On 24Jan2021 17:00, patient experienced swelling in the area at the base of the neck on the left shoulder, (there was a small lump in that area) and soreness/tenderness in the area near the collarbone. Patient had not recovered from the events and had not received any treatment. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.

Other Meds: losartan potassium; Aleve

Current Illness:

ID: 1018372
Sex: F
Age:
State: CA

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: itchy skin; itchy throat; Dizziness; This is a spontaneous report from a contactable nurse reporting for self. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot# E19261, Dose 1, via an unspecified route of administration on 22Jan2021 13:30 (at the age of 43 years old) as a single dose in left arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Medical history included asthma. The patient reported allergy to sulfa and amoxicillin sodium;clavulanate potassium (AUGMENTIN). The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA). On 22Jan2021, the patient experienced dizziness within 5 minutes after vaccine that lasted 2 hours, itchy throat started within 10 min and itchy skin started 2 hrs post vaccine. As treatment for the events, the patient received diphenhydramine (BENADRYL) at home. There was no hospitalization for the events. The events were reported as non-serious. The clinical outcome of the events dizziness, itchy throat, and itchy skin was recovering. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: BREO ELLIPTA

Current Illness:

ID: 1018373
Sex: F
Age:
State: NM

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Hot painful red rash on abdominal area; Hot painful red rash on abdominal area; welts; swelling; This is a spontaneous report from a contactable other hcp. A 56-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration at single dose left arm on 23Jan2021 11:15 for covid-19 immunisation. Medical history included thyroid disorder, breast cancer female, migraine, allergy to sulfonamide and topamax, food allergy. Concomitant medications included levothyroxine, liothyronine (NP THYROID), multivitamin, plant based calci. The patient experienced hot painful red rash on abdominal area on 23Jan2021 18:00, welts on 23Jan2021 18:00, swelling on 23Jan2021 18:00. No treatment received. The outcome was not recovered. Information on the lot/batch number has been requested

Other Meds: NP THYROID

Current Illness:

ID: 1018374
Sex: M
Age:
State: OH

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Had a fall and hit his head; Had a fall and hit his head; This is a spontaneous report from a contactable pharmacist. A 83-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 23Jan2021 (age at vaccination: 83 years old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the 1st vaccine dose "today" (23Jan2021) but he had a fall and hit his head. Patient was now requiring TDAP. The clinical outcome of the event fell and his head was unknown. The reporting pharmacist was seeking information on the use with other vaccines, particularly the benefit vs risk of co-administering in an emergency case. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1018375
Sex: F
Age:
State: CA

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210123; Test Name: fever; Result Unstructured Data: Test Result:102.7

Allergies:

Symptoms: Fever 102.7; severe myalgia/arthralgia; severe myalgia/arthralgia; sore throat; profuse sweating; Headache; swollen lymph nodes; This is a spontaneous report from a contactable nurse reporting for self. A 37-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Dose 2, via an unspecified route of administration on 22Jan2021 16:30 (at the age of 37 years old) as a single dose in left arm for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included dyslipidemia, hypothyroid, bipolar type 2,and sleep apnea. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included atorvastatin, lamotrigine, and levothyroxine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Dose 1, as a single dose on an unspecified date for COVID-19 immunization. On 23Jan2021 01:00, the patient experienced fever102.7, severe myalgia/arthralgia, sore throat,headache, profuse sweating, and swollen lymph nodes. As treatment for the events, the patient received acetaminophen and ibuprofen. No hospitalization was required. The events were reported as non-serious. The clinical outcome of the events fever102.7, severe myalgia/arthralgia, sore throat, headache, profuse sweating, and swollen lymph nodes was not recovered. Since the vaccination, the patient has not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: ATORVASTATIN; LAMOTRIGINE; LEVOTHYROXINE

Current Illness:

ID: 1018376
Sex: M
Age:
State: FL

Vax Date: 12/29/2020
Onset Date: 01/17/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210117; Test Name: IgG; Test Result: Negative ; Comments: On day 19 after the vaccine; Test Date: 20210118; Test Name: IgG; Test Result: Negative ; Comments: On day 20 after vaccination; Test Date: 20210117; Test Name: IgM; Test Result: Negative ; Comments: On day 19 after the vaccine; Test Date: 20210118; Test Name: IgM; Test Result: Negative ; Comments: On day 20 after vaccination

Allergies:

Symptoms: On day 19 after the vaccine was given I tested them for antibodies to the virus, they both were negative for IgM and IgG.; This is a spontaneous report from a contactable Physician who reported similar events for two patients. This is the first of two reports. An 84-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: eh9899), intramuscular in left arm on 29Dec2020 10:30 at single dose for covid-19 immunisation. Medical history included hypertension, benign prostatic hyperplasia, lipids increased. Concomitant medication included asa (ASA), ascorbic acid, betacarotene, cupric oxide, manganese sulfate, selenium, tocopheryl acetate, ubidecarenone, zinc oxide (COQ10), finasteride (unknown manufacturer), fish oil (unknown manufacturer), hydroxychloroquine (unknown manufacturer), furosemide (LASIX), atorvastatin (LIPITOR), lisinopril (unknown manufacturer), levothyroxine sodium (SYNTHROID), vitamin b complex (unknown manufacturer), vitamin c [ascorbic acid] (unknown manufacturer), vitamin d3 (unknown manufacturer), zinc (unknown manufacturer). On 17Jan2021, day 19 after the vaccine, the patient was tested for antibodies to the virus, and was negative for igm and igg. Test was negative also on 18Jan2021, day 20 after their vaccination, the day before his second vaccination. No treatment was performed. The outcome of the event was recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021086757 same reporter/drug/event, different patient

Other Meds: ASA; COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECA; FINASTERIDE; FISH OIL; HYDROXYCHLOROQUINE; LASIX [FUROSEMIDE]; LIPITOR [ATORVASTATIN]; LISINOPRIL; SYNTHROID; VITAMIN B COMPLEX; VITA

Current Illness:

ID: 1018377
Sex: F
Age:
State: SC

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Racing heart; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number: EL3249), via an unspecified route of administration in the left arm on 21Jan2021 at 11:00 (at the age of 72-years-old) as a single dose for COVID-19 immunization. Medical history included hypertension. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. The patient's concomitant medications included atenolol, bio-identical hormones and deplane (information presented as reported). The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 22Jan2021 at 15:45, the patient experienced racing heart. The patient reported that when walking she had to sit down to get heart back in rhythm, the patient was still experiencing the event, even when not walking. The patient stated it was a bit un-nerving and that the patient is a strong walker. The patient did not receive any treatment for the event. The clinical outcome of the racing heart was recovered with sequalae (reported as "Recovered with lasting effects") on an unknown date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: ATENOLOL

Current Illness:

ID: 1018378
Sex: M
Age:
State:

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: a little pain between shoulder blade; baggy eyes; This is a spontaneous report from a non-contactable consumer. This male consumer (patient) reported that: Narrative case summary and further information: Originating AE Request: REQ-# Attachments: 1 Patient Age: unknown Reporter Subtype: Patient PQC Present: No AE Present: Yes Request Name: REQ-# Product: PFIZER-BIONTECH COVID-19 VACCINE Question: Caller, male, received vaccine yesterday 22Jan2021 and only reports minor side effects (a little pain between shoulder blade and baggy eyes) and already filed safety report. Calling to see if there is any fish oil in the vaccine due to a squalene/fish oil allergy? This is a spontaneous report from a non-contactable consumer, the patient. This male patient of unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on 22Jan2021 as a single dose for COVID-19 immunization. The patient's medical history included squalene/fish oil allergy from an unspecified date and unknown if ongoing. Concomitant medications were not reported. On an unspecified date in Jan2021, the patient experienced only minor side effects, a little pain between shoulder blade and baggy eyes. The clinical outcome of the events numbness and tingling was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. This is a spontaneous report from a non-contactable consumer or other non hcp. A male patient of an unspecified age started to receive bnt162b2 (BNT162B2) , via an unspecified route of administration from 22Jan2021 to 22Jan2021 at SINGLE DOSE for an unspecified indication . Medical history included food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced a little pain between shoulder blade and baggy eyes (pain) (non-serious) on an unspecified date with outcome of unknown. The action taken in response to the event(s) for bnt162b2 was not applicable.

Other Meds:

Current Illness:

ID: 1018379
Sex: F
Age:
State: WI

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: prod cough; SEVERE body aches; shortness of breath on exertion; inj site pain; exhaustion; headache; fever; patient received IMURAN concomitantly; patient received IMURAN concomitantly; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL 0142) via an unspecified route of administration in left arm on 21Jan2021 17:30 at single dose for COVID-19 immunization. Medical history included Crohn's disease, migraine. Concomitant medication included azathioprine (IMURAN), propranolol, sertraline hydrochloride (ZOLOFT). The patient previously took infliximab (REMICADE) and morphine, both experienced drug allergy; received the first dose of bnt162b2 (Lot number: EL1284) in left arm for COVID-19 immunization and experienced severe body aches, headache, heavy feeling injection arm unable to lift it, cough and exhaustion. The patient experienced prod cough, severe body aches, shortness of breath on exertion, inj site pain, exhaustion, headache, fever, all on 22Jan2021 05:00. No treatment received for the adverse events. Reporter considered the events as non-serious. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.

Other Meds: IMURAN [AZATHIOPRINE]; PROPRANOLOL; ZOLOFT

Current Illness:

ID: 1018380
Sex: F
Age:
State: NC

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe headaches; This is a spontaneous report from a contactable nurse reporting for herself. A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EJ1685/expiration date: not provided), via intramuscular route of administration, on 29Dec2020 07:45 AM (at the age of 53 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history included multiple sclerosis (MS) and is a breast cancer (CA) survivor. The patient has known allergies to seafood and diazepam (VALIUM). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included dimethyl fumarate (TECFIDERA), tamoxifen, and acetylsalicylic acid (ASPIRINE). The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Dec2020 at 06:00, the patient experienced severe headaches for a 1 month with no relief from acetaminophen (TYLENOL) or ibuprofen every 6 hours. The patient had to go to emergency room (ER) to get migraine treatment. The event severe headache was reported as non-serious and did not require hospitalization. The event severe headache required a physician office visit and an emergency room visit. The patient received treatment for the event severe headache which included acetaminophen, diphenhydramine (BENADRYL) toradol, prochlorperazine (COMPAZINE), and sodium chloride. The outcome of the event severe headaches was recovered on an unspecified date in 2021. Since the vaccination, the patient had been tested for COVID-19 via nasal swab on 19Jan2021 which was negative.

Other Meds: TECFIDERA; TAMOXIFEN; ASPIRINE

Current Illness:

ID: 1018381
Sex: F
Age:
State: NY

Vax Date: 12/30/2020
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection sight tenderness; Fatigue; Severe headache; This is a spontaneous report from a contactable other HCP report for self. This 30-year-old not pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140) intramuscular at left arm on 30Dec2020 at single dose for COVID-19 immunization. Medical history included Asthma, anxiety, allergies to Acetaminophen (seizure like activity and fainting). No COVID prior vaccination. No other vaccine in four weeks. Concomitant medications include Fluoxetine, lorazepam, and Ibuprofen. Patient experienced injection sight tenderness, severe headache for 5 days, fatigue for 7-10 days after first dose. The outcome of events was unknown.

Other Meds: Fluoxetine; Lorazepam; Ibuprofen

Current Illness:

ID: 1018382
Sex: F
Age:
State: NY

Vax Date: 01/11/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe nausea and vomiting/diarrhea; severe nausea and vomiting/diarrhea; severe nausea and vomiting/diarrhea; Chills; body aches; tired and slept all day; Tingling at fingertips; This is a spontaneous report from a contactable consumer(patient). The 49-year-old female patient(not pregnant) received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot: EL3247), via an unspecified route of administration at left arm on 11Jan2021 16:30 at single dose for covid-19 immunisation. Medical history included hashimotos disease, allergy to penicillin and sulfa, tree nut intolerance. There was no COVID-19 Prior to vaccination. Concomitant medication included levothyroxine sodium (UNITHROID), ethinylestradiol/levonorgestrel (ENPRESSE). There was no other vaccination within 4 weeks prior to the COVID vaccine. On 22Jan2021, 04:00, The patient woke up with severe nausea and vomiting/diarrhea, lasted for the morning, she also experienced chills and body aches. By noon she was fine but tired and slept all day. She also experienced tingling at fingertips. That was all done by night. There was no treatment. Outcome of events was recovered in 22Jan2021. Events were assessed as non-serious. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds: UNITHROID; ENPRESSE

Current Illness:

ID: 1018383
Sex: F
Age:
State: ID

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: diarrhea; I still don't feel quite well; i felt almost like a mild fever; light headed; little nauseated; quite chilled; had nausea that worsened when lying down and felt like i was drunk (balance/coordination, clarity of thought); had nausea that worsened when lying down and felt like i was drunk (balance/coordination, clarity of thought); This is a spontaneous report from a contactable consumer (patient). This 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL3246/expiration date: unknown), via unknown route of administration, on 19Jan2021 03:30 PM (at the age of 56 years old) as a single dose on left arm for COVID-19 immunisation for COVID-19 immunisation at a hospital. Relevant medical history included hypothyroid, hypertension, celiac, chronic dermatitis. The patient allergic to statins, gluten-intolerant (celiac). The patient was not pregnant at time of vaccination. Relevant concomitant medications included Levothyroxine, Irbesartin, Vitamins. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that on 19Jan2021 10:30 PM, about 7 hours after the shot and for the next 12 hours, she was quite chilled, had nausea that worsened when lying down and felt like she was drunk (balance/coordination, clarity of thought). After 12 hours of those symptoms, the drunk feeling and nausea were gone but she has since then struggled with diarrhea if she eats anything not completely bland, including today (4 days later). She stated "I still don't feel quite well and if I am very active (like she was packing boxes last night), I felt almost like a mild fever, light headed and a little nauseated." The outcome of the events chills, nausea, feeling drunk was recovered after 12 hrs later. The outcome of events diarrhea, don't feel quite well, fever, light headed and nauseated was not recovered. No treatment was received for the events. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1018384
Sex: M
Age:
State: NY

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild arm soreness; This is a spontaneous report from a Pfizer-sponsored program from a non-contactable male consumer, the patient. A male patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown) , dose 1, single dose via unspecified route of administration on 22Jan2021 for COVID-19 vaccination. Medical history and concomitant medications were unknown. On an unknown date, the patient experienced mild arm soreness. It was unknown if the patient received treatment for the event. The clinical outcome of mild arm soreness was unknown. No follow-up attempts are possible; Information about Lot/Batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1018385
Sex: F
Age:
State: AR

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; chills; fever; sweats; joint and muscle pain; joint and muscle pain; exhaustion; This is a spontaneous report from a contactable nurse, the patient. A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL3302) , dose 2, single dose via Intramuscular route of administration in the right arm on 21Jan2021 at 09:00 AM (at the age of 48 years-old) for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included allergies to penicillin and sulfa drugs. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included ibuprofen. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EJ1686), single dose, dose 1, intramuscular route of administration in the left arm on 31Dec2020 at 07:30 AM. On 21Jan2021 at 09:00 PM, the patient experienced headache, chills, fever, sweats, joint and muscle pain and exhaustion. It was unknown if the patient received treatment for the event. The events were reported as non-serious. The clinical outcome of headache, chills, fever, sweats, joint and muscle pain and exhaustion was not recovered. There was no treatment received for the events. It was also reported that since the vaccination, the patient had been tested for COVID-19.

Other Meds: IBUPROFEN

Current Illness:

ID: 1018387
Sex: F
Age:
State: MA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; night sweats; chills; headache; nausea; administration date=21/01/2021. dose number=2/administration date=04Jan2021. dose number=1; This is a spontaneous report from a contactable physician (patient). A 34-years-old female patient (no pregnant) received the second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), intramuscular on 21Jan2021 11:30 at SINGLE DOSE at left arm for covid-19 immunisation. The patient received the first dose of bnt162b2 on 04Jan2021 for covid-19 immunisation. Medical history included gastrooesophageal reflux disease, allergy to Sulfa. Concomitant medication included pantoprazole, spironolactone, and multivitamin. The patient experienced fever, night sweats, chills, headache, nausea on 22Jan2021 02:30. The patient received ibuprofen and acetaminophen for fever, night sweats, chills, headache, nausea. The outcome of events was recovering.

Other Meds: Pantoprazole; Spironolactone

Current Illness:

ID: 1018389
Sex: F
Age:
State: MO

Vax Date: 01/19/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: vertigo/dizziness; vertigo/dizziness; Chills; body aches; extreme tiredness; bilateral ear pain; nausea; No appetite; This is a spontaneous report from a contactable Other healthcare professional (HCP) reporting for herself. A 56-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at let arm on 19Jan2021 17:00 at single dose for covid-19 immunization. The patient was not pregnant. The COVID-19 vaccine was administered at Hospital. The patient medical history reported as none. Concomitant medication included cimicifuga racemosa (BLACK COHOSH), curcuma longa (TURMERIC). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 on 29Dec2020 07:00 at left arm for covid-19 immunization. The patient experienced Chills, body aches, extreme tiredness (slept for 30+ hours), bilateral ear pain, nausea - this all started 15 hours after 2nd dose on 20Jan2021 08:00, and then vertigo/dizziness started 4 days after 2nd dose on 23Jan2021, and also experienced no appetite from an unknown date in Jan2021. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds: BLACK COHOSH [CIMICIFUGA RACEMOSA]; TURMERIC [CURCUMA LONGA]

Current Illness:

ID: 1018390
Sex: M
Age:
State: NC

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; body aches; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot number EL3247), via an unspecified route of administration on 22Jan2021 at 09:45 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included a history of COVID-19 infection on an unspecified date. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) 150 mg and "Larsortin" 50 mg. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in Jan2021 the patient experienced fever, chills and body aches. The patient did not receive any treatment for the events. The clinical outcomes fever, chills and body aches were reported as not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds: Wellbutrin

Current Illness:

ID: 1018392
Sex: M
Age:
State: CO

Vax Date: 12/30/2020
Onset Date: 01/10/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tiredness; sleepiness; muscle and joint pain; muscle and joint pain; nausea; lack of appetite; fatigue; feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number number number EX9231), via an unspecified route of administration on 30Dec2020 (at the age of 75-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included metastatic melanoma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included prednisone (MANUFACTURER UNKNOWN), amoxicillin (AMOXICILLIN) and vitamins (MANUFACTURER UNKNOWN) all from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jan2021, the patient experienced tiredness, sleepiness, muscle and joint pain, nausea, lack of appetite, fatigue and feeling unwell. The patient mentioned that he was unsure if this is from vaccine or "other treatment or cancer." The patient did not receive any treatment for the events. The clinical outcomes of tiredness, sleepiness, muscle and joint pain, nausea, lack of appetite, fatigue and feeling unwell were reported as not recovered. It was additionally reported that the patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number E3246) on 20Jan2021 as a single dose in the left arm. It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible; information about lot number cannot be obtained.

Other Meds: Prednisone; Amoxicillin

Current Illness:

ID: 1018393
Sex: F
Age:
State: MO

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: woke up 1/23/21 with redness at injection site; a rash on the arm of said injection, right arm; a rash on the arm of said injection, right arm; This is a spontaneous report from a contactable healthcare professional who is the patient. A 32-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL3247), intramuscularly on 22Jan2021 at 08:45 (at the age of 32-years-old) as a single dose in the right arm for COVID-19 vaccination. Medical history included AV node re-entrant phenomenon. The patient's historical vaccinations included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL3246) intramuscularly in the right arm on 31Dec2020 at 8:30 AM. The patient is allergic to morphine and "Celcor." The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ivabradine hydrochloride (CORLANOR) 5 mg half tablet twice daily with food. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient woke up on 23Jan2021 at 08:00 with redness at the injection site and a rash on the arm of said injection site (right arm). The patient did not receive any treatment for the events. The clinical outcomes of the events injection site redness and rash were reported as recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: CORLANOR

Current Illness:

ID: 1018395
Sex: F
Age:
State: OH

Vax Date: 12/29/2020
Onset Date: 12/31/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: splitting headaches; chronic nausea; Vomiting is explosive and unpredictable; metallic taste in mouth for 3 days.; This is a spontaneous report from a contactable other hcp, the patient. This 61-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EK5730), dose number 1, via an unspecified route of administration in the right arm on 29Dec2020 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunization. Medical history included type 1 diabetes mellitus from 1974 to an unknown date (T1DM dx 1974) and aortic valve replacement from 1990 and unknown if ongoing (AVR 1990 and 1992). Concomitant medication included insulin (INSULIN), simvastatin (SIMVASTATIN) and lisinopril (LISINOPRIL). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. On 31Dec2020, the patient experienced metallic taste in mouth for 3 days. On 07Jan2021 at 13:00, the patient experienced splitting headaches, chronic nausea began and vomiting which was explosive and unpredictable. No therapeutic measures were taken as a result of the events. The clinical outcomes of the metallic taste in mouth for 3 days, splitting headaches, vomiting and chronic nausea were not resolved. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: INSULIN; SIMVASTATIN; LISINOPRIL

Current Illness:

ID: 1018396
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: Blood pressure; Result Unstructured Data: Test Result: High; Comments: 85 year old female patient had high blood pressure and a headache after receiving the first dose

Allergies:

Symptoms: 85 year old female patient had high blood pressure and a headache after receiving the first dose; 85 year old female patient had high blood pressure and a headache after receiving the first dose; This is a spontaneous report from a contactable consumer (patient). An 85-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE ), via an unspecified route of administration, on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. On an unspecified date, the patient experienced high blood pressure and a headache after receiving the first dose. The headache would be off and on. The clinical outcome of the events high blood pressure and a headache were unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018397
Sex: F
Age:
State: IL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: temperature; Result Unstructured Data: Test Result:97.4; Test Date: 20210122; Test Name: heart rate; Result Unstructured Data: Test Result:93; Comments: bpm

Allergies:

Symptoms: raised welts if is scratched; felt very warm; itching; developed a rash all over the trunk; I took my temperature and it was 97.4; My heart rate jumped to 93bpm; This is a spontaneous report from a contactable consumer (patient). This 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EL8982), via an unspecified route of administration on 22Jan2021 17:45 at single dose on the left arm for COVID-19 immunization. The patient medical history included hypothyroidism, inflammation and sensitive to grains. Patient received other medications within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was hospital. Patient was not pregnant at the time of vaccination. Approximately 4 hours after patient received the vaccination (22Jan2021 21:45), she felt very warm, and she started itching. Patient developed a rash all over the trunk. Patient took her temperature and it was 97.4. Patient heart rate jumped to 93bpm. Patient took a diphenhydramine hydrochloride (BENADRYL). As soon as the diphenhydramine hydrochloride took effect, her heart lowered pretty quickly. When patient woke up this morning (23Jan2021), she was still itching mildly and raised welts if is scratched. More diphenhydramine hydrochloride four hours ago. Treatment received for the adverse event included diphenhydramine hydrochloride (self administered). Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Outcome of the event was recovering. The events were reported as non-serious.

Other Meds:

Current Illness:

ID: 1018399
Sex: F
Age:
State: OH

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: vision clouded, and it progressed towards the night; This is a spontaneous report from a contactable consumer (patient). A 90-year old female patient (not pregnant) received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EL9261 and Expiration Date 31May2021) via an unspecified route of administration on 21Jan2021 at single dose for COVID-19 immunisation. The patient's medical history included hypertension and AFib. The concomitant medications were included apixaban (ELIQUIS) at 5 mg, dofetilide at 250mg, metoprolol at 60 mg for hypertension. Patient mentioned that about 6-7 hours after she received the vaccine on 21Jan2021, her vision clouded, and it progressed towards the night. First it began in right eye and it started it was the time when patient usually retire so she went to bed and when woke up and vision was extremely clouded (both eyes). Patient had the night light on and could not see the night light. She could just see a glow. The morning after, it was gone. She said that she normally has perfect vision and never had this experience before. She says it was not an issue right now since it went away. She wanted to know if she should be concerned and wanted to report this event because it was bothersome and other people might have a similar experience. Not taking second shot if it was going to cause problem; concerned of getting 2nd shot. The outcome of events was recovered on 22Jan2021 without treatment given. No follow-up attempts are possible. No further information is expected.

Other Meds: Eliquis; Dofetilide; Metoprolol

Current Illness:

ID: 1018400
Sex: F
Age:
State: HI

Vax Date: 01/19/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; Body ache; Headache; Nausea; Fatigue; Keep biting my teeth; This is a Spontaneous report from a Contactable Other HCP (Patient). A 49-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at 16:45 at single dose in left arm for COVID-19 immunisation. Patient age at vaccination was 49 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history was none. The patient had no known allergies. Concomitant medications included pravastatin sodium, olmesartan, olmesartan medoxomil, and collagen peptides. On 23Jan2021 at 23:30 the patient experienced chills, body ache, headache, nausea, fatigue and keep biting my teeth. No treatment was received for the events. The events had not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. Information about Lot/batch no has been requested.

Other Meds: PRAVASTATIN SODIUM; OLMESARTAN; OLMESARTAN MEDOXOMIL

Current Illness:

ID: 1018402
Sex: F
Age:
State: MI

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: burning sensation; severe blistering raised rash on right leg, arm, buttcheek and back; severe blistering raised rash on right leg, arm, buttcheek and back; Dermatitis; the rash/it is red; This is a spontaneous report from a contactable Consumer (patient). A 63-year-old female patient received bnt162b2 (lot number: EL3249, Expiry Date: May2021), via an unspecified route of administration on 15Jan2021 at single dose for covid-19 immunization. Medical history included Hiatal hernia, heartburn and stuff. The patient's concomitant medications was unspecified medication for heartburn and stuff. The patient previously took clindamycin and allergy. The patient received vaccine on 15Jan2021, started developing severe blistering raised rash on right leg, arm, buttcheek and back on Jan2021. The patient experienced rash, now raised and blistering. On 15Jan2021, legs butt cheeks on back right side of body (same side of body) burning sensation. Patient got a dermatitis on Jan2021. She don't know what dermatitis looks like but the rash she got, it like raised up and it is red and some of it is like blistered. Because she got like a blistering rash at first it was just a rash then it started kind of blistering. They have gotten worsened, they started Monday or Tuesday (Jan2021), the rash started but its got worse since then and spread. She just put some Calmoseptine on it. It is over the counter, it is almost like a diaper rash that she used on it. But she kind of got like the burning sensation too. Its an ointment. It is like a diaper rash ointment. She figured she would try that because she did an antibiotic ointment (Unspecified Ointment) and it didn't work at all. The outcome of the event burning sensation was unknown, other events was not recovered.

Other Meds:

Current Illness:

ID: 1018403
Sex: F
Age:
State: FL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she had a reaction on her face. She described it as her cheeks turning red, rashy, and itchy; my eyes were just little bit itchy; This is a spontaneous report from a contactable nurse reporting for self. A 69-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), intramuscular on 22Jan2021 at single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included letrozole (FEMARA), Antioxidants and Vitamins. The patient had a reaction on her face. She described it as her cheeks turning red, rashy, and itchy. Within 24 hours, it went away. She mentioned that she used a different face mask yesterday and wasn't sure if it is a reaction from the vaccine or from her face mask. Her eyes were just little bit itchy. It started about an hour and a half and within three hours it was gone. Outcome of events was recovered.

Other Meds: Femara

Current Illness:

ID: 1018404
Sex: M
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: psoriasis spread all over body and patient was really covered with it; This is a spontaneous report from a contactable consumer reported for himself. An 87-year-old male patient received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. Medical history included psoriasis on his legs, had reactions to medications (doesn't specify which ones) in the past that have resulted in sleeping problems, stress and heightened blood pressure. The patient's concomitant medications were not reported. Patient had his first dose of the vaccine on 09Jan2021. He has psoriasis on his legs at baseline but reports that a few days after the vaccine the psoriasis spread all over body and patient was really covered with it. Patient was working with a dermatologist. The event outcome was unknown. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1018406
Sex: F
Age:
State: HI

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Burning tongue; Dry mouth; This is a spontaneous report from a contactable other Health Professional (patient). A 27-year-old female patient received the first dose of bnt162b2 (Lot/batch number and Expiration date were not provided), intramuscular in left arm on 15Jan2021 12:00 at single dose for covid-19 immunization. Medical history included Asthma. Concomitant medication included ibuprofen (ADVIL), cetirizine hydrochloride (ZYRTEC). The patient previously took amoxicillin and experienced allergies. The patient experienced burning tongue, dry mouth on 15Jan2021 13:30. No treatment received. The patient was not pregnant. The outcome of the events was recovered on Jan2021. No follow up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: Advil [Ibuprofen]; Zyrtec [Cetirizine Hydrochloride]

Current Illness:

ID: 1018407
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: stiffening of her arm; This is a spontaneous report from a contactable Consumer report for self. A 90-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization, arnica montana (ARNICA (PLANTA TOTA) "WELEDA") via an unspecified route of administration from an unspecified date to an unspecified date at unspecified dose for an unspecified indication. Medical history included hearing is not good. Concomitant medications not reported. Patient experienced no serious side effect other than stiffening of her arm, she took some Arnica before went for the shot and after, and she had practically no side effects, just a little stiffness but that just lasted a day. She is scheduled to take the 2nd dose on 29Jan2021 8am and is concerned that she may experience greater side effects and flu like symptoms after. She lives alone in an apartment and is asking if she should get someone to look her after the 2nd shot. Action taken for arnica montana was unknown. Event outcome was recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018409
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: legs were weak and can't barely walk; legs were weak and can't barely walk; bad Cough; sore throat; headache; nausea; chills; This is a spontaneous report from a contactable consumer (patient). This 75-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route on 18Jan2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 21Jan2021, the patient experienced nausea, chills, and headache. On 22Jan2021 she experienced bad cough, sore throat, legs were weak and can't barely walk. The outcome of the events nausea, chills, headache, bad cough, sore throat, legs were weak, and can't barely walk were unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 1018410
Sex: F
Age:
State: NC

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild itchy rash on neck and chest; This is a spontaneous report from a contactable healthcare professional (patient). This 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration in the right arm on 21Jan2021 at 10:30 (at the age of 39-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. The patient did not have any allergies. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine, omeprazole, and birth control. The patient did not have any other vaccines within 4 weeks prior to the vaccine. On 22Jan2021, the patient experienced a mild itchy rash on the neck and chest. The patient did not receive any treatment for the event. The outcome of the rash was recovered. It was also reported that since vaccination, the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: LEVOTHYROXINE; OMEPRAZOLE

Current Illness:

ID: 1018412
Sex: M
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore throat; feels tired; a bit achy; This is a spontaneous report from a contactable consumer (patient's wife). A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration on 16Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter's husband got his Covid vaccine last week. The patient's wife mentioned that he developed a sore throat 4 days after receiving the vaccine (20Jan2021) and wanted to know if this was a normal reaction from the vaccine and if this will happen again once he receives his 2nd dose. Also added that he also feels tired and a bit achy. The outcome of the event sore throat was not recovered while of the other events was unknown.

Other Meds:

Current Illness:

ID: 1018413
Sex: F
Age:
State: VA

Vax Date: 01/20/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210123; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Chest pain/pressure; Flushing; General fatigue; Presyncopal event; Migraine; Left arm tingling; Chest pain/pressure; This is a spontaneous report from a contactable nurse reporting for self. A 34-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3302), intramuscular on 20Jan2021 10:00 at single dose for COVID-19 immunization. Medical history included coeliac disease, polycystic ovaries, migraine, drug hypersensitivity to Sulfa. Concomitant medication included clarithromycin (MACROBID [CLARITHROMYCIN]). The patient experienced flushing and general fatigue. Presyncopal event and migraine on day 3 without prior indication 23Jan2021. Left arm tingling and chest pain and pressure. Therapeutic measures Motrin were taken as a result of flushing and migraine. Patient had Covid test type post vaccination on 23Jan2021 with negative result. Outcome of events was recovering. All events resulted in emergency room visit.

Other Meds: MACROBID [CLARITHROMYCIN]

Current Illness:

ID: 1018415
Sex: M
Age:
State: CA

Vax Date: 01/16/2021
Onset Date: 01/18/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: hypertension; Result Unstructured Data: Test Result: mild hypertension like symptoms.

Allergies:

Symptoms: slight concentration issues; mild swelling similar to a histamine reaction; mild swelling similar to a histamine reaction; muscle tenderness; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 16Jan2021 11:00 at single dose in left arm for COVID-19 immunization. Medical history included mild allergies to pollens, insomnia, ongoing hypertension from years ago. Concomitant medications in two weeks included mirtazapine, ibuprofen. Facility type vaccine was Workplace clinic. No other vaccine in four weeks. On 18Jan2021 13:00, the patient experienced mild hypertension like symptoms, mild swelling similar to a histamine reaction, muscle tenderness, and slight concentration issues. No treatment received for the events. No COVID prior vaccination. No COVID tested post vaccination. The outcome of the events was recovering. Information about batch/lot number has been requested.

Other Meds: MIRTAZAPINE; IBUPROFEN

Current Illness: Hypertension (years ago)

ID: 1018416
Sex: F
Age:
State: AR

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Painful, golf ball size swollen right axillary lymph node; Painful, golf ball size swollen right axillary lymph node; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), intramuscular on 21Jan2021 - 02:00 pm at a single dose on the right arm for COVID-19 immunization. The vaccine was administered at a hospital. She did not receive other vaccines in four weeks prior to receiving bnt162b2. It was unknown if patient had covid prior to vaccination. Medical history included known allergies: latex and other chronic allergies. The patient was not pregnant. Concomitant medications included cetirizine hydrochloride (ZYRTEC), naproxen (NAPROXEN), colecalciferol (VITAMIN D), and melatonin (MELATONIN). The patient previously received the first dose of bnt162b2 (BNT162B2), intramuscular on 30Dec2020 - 11:00 pm at a single dose on the left arm for COVID-19 immunization (age at the time of vaccination: 38-year-old). On 23Jan2021 10:00 pm, the patient had a painful, golf ball size swollen right axillary lymph node. The patient was not tested for covid post vaccination. No treatment was received in response to the events. Outcome of the events was recovering. Information about Lot/Batch number is requested.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; NAPROXEN; VITAMIN D [COLECALCIFEROL]; MELATONIN

Current Illness:

ID: 1018418
Sex: F
Age:
State: NY

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Skin Lesion on right back of calf. It is about 3/4" in size, flaky, dark red and purple, tender to touch, dry; Skin Lesion on right back of calf Skin Lesion on right back of calf. It is about 3/4" in size, flaky, dark red and purple, tender to touch, dry; Skin Lesion on right back of calf Skin Lesion on right back of calf. It is about 3/4" in size, flaky, dark red and purple, tender to touch, dry; Skin Lesion on right back of calf Skin Lesion on right back of calf. It is about 3/4" in size, flaky, dark red and purple, tender to touch, dry; Skin Lesion on right back of calf Skin Lesion on right back of calf. It is about 3/4" in size, flaky, dark red and purple, tender to touch, dry; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female non-pregnant patient received first dose of bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3247), via an unspecified route of administration on 18Jan2021 11:00 at SINGLE DOSE at left arm for covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered was Other. Medical history included allergies to Penicillin. The patient had no other medical history. The patient's concomitant medications were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced skin lesion on right back of calf from 19Jan2021. It was about 3/4 in size, flaky, dark red and purple, tender to touch, dry and after several days of careful care and cleaning it had not gotten better or gone away. Outcome of the events was not recovered. No treatment received for the adverse event.

Other Meds:

Current Illness:

ID: 1018419
Sex: F
Age:
State: OK

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dizziness while lying in bed after turning over onto her back/ dizziness when standing up quick, turning over onto her back or side while in bed, and getting out of her car; had been a few times while lying in bed that her vision was affected when this dizziness comes on; This is a spontaneous report from a contactable consumer (reported for herself). A 56-year-old female patient (not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EK9231), via an unspecified route of administration on 07Jan2021 15:00 at single dose in right arm for COVID-19 immunization. Medical history included Hypothyroidism, No Allergies to medications, food, or other products. Concomitant medication received within 2 weeks of vaccination included levothyroxine. Facility where the most recent COVID-19 vaccine was administered in Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Vaccine was given on a Thursday afternoon, on Saturday morning, the patient experienced a dizziness while lying in bed after turning over onto her back. She only experienced the dizziness when standing up quick, turning over onto her back or side while in bed, and getting out of her car. She had never had any trouble with dizziness. There had been a few times while lying in bed that her vision was affected when this dizziness comes on. To date she was still having problems. The events started on 09Jan2021 06:30. No any treatment received for the adverse events. The events were non-serious per the reporter. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was not recovered.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1018420
Sex: F
Age:
State:

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arthritis; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer. This female patient of unspecified age received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 23Jan2021 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The patient received her first dose of vaccine on 23Jan2021 (reported as "today") and would get Remicade on Monday for her arthritis. The patient asked if it was safe and if it would affect the vaccine. Outcome of the event was unknown. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1018421
Sex: F
Age:
State: MN

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain in the lower, inner aspect muscle of upper right arm. Radiants to muscle just below the elbow. Both muscles hurt when stretching or picking something, even the TV remote, up; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number= EJ1686), via an unspecified route of administration at right arm on 19Jan2021 13:45 at single dose for covid-19 immunisation. Medical history included multiple sclerosis, hypertension. The patient received any other medications within 2 weeks of vaccination as prescribed. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Jan2021, The patient experienced pain in the lower, inner aspect muscle of upper right arm. Radiants to muscle just below the elbow. Both muscles hurt when stretching or picking something, even the TV remote, up. The patient was concerned she may drop something. It started day after having the shot and had been 4 days. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 1018423
Sex: F
Age:
State: CA

Vax Date: 01/14/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Six days after the shot I had a severe rash/hives all over my body; Six days after the shot I had a severe rash/hives all over my body; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL1284), via an unspecified route of administration on 14Jan2021 03:15 at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included Colitis, Arthritis, Allergies to Penicillin, Allergies to Mugwort. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included celecoxib (CELEBREX). The patient experienced ''six days after the shot i had a severe rash/hives all over my body'' (non-serious) on 20Jan2021 07:00. AEs resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Patient was not pregnant. Therapeutic measures were taken as a result of events (treatment: benedryl, zyrtec, Pepcid). The outcome of events was not recovered.

Other Meds: Celebrex

Current Illness:

ID: 1018424
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19 antibody; Result Unstructured Data: Test Result:had zero antibodies; Test Date: 202101; Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: tested positive for covid 3-4 days afterward; tested positive for covid 3-4 days afterward; This is a spontaneous report from a contactable consumer. This male consumer of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. The consumer received first dose 20 days before in Jan2021 and tested positive for COVID 3-4 days afterward in Jan2021. He was tested himself after 15 days and it said he had zero antibodies in Jan2021. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018426
Sex: F
Age:
State: WA

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210123; Test Name: Heart rate; Result Unstructured Data: Test Result:127; Comments: heart rate went up to 127, then stayed in the mid 80's.; Test Date: 20210123; Test Name: Heart rate; Result Unstructured Data: Test Result:80; Comments: heart rate went up to 127, then stayed in the mid 80's.

Allergies:

Symptoms: allergy; cold; heart rate went up to 127, then stayed in the mid 80's; This is a spontaneous report from a contactable consumer (patient). This a 72-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number and expiry date: not reported), via an unspecified route of administration, on 22Jan2021 03:45 PM at a single dose on the right arm for COVID-19 immunization. The patient was not pregnant. The patient had not received other vaccines in four weeks prior to receiving bnt162b2. Medical history included Hashimoto's, and allergy to statins and fluoroquinolones. The patient had no covid prior to vaccination. Concomitant medication included levothyroxine sodium (SYNTHROID) and liothyronine sodium (CYTOMEL). The patient also received another vaccine (unspecified), first dose on 22Jan2021 on the right arm. At about 12:30 or 1:00 pm on Saturday, 23Jan2021, the patient's heart rate went up to 127, then stayed in the mid 80's. She felt like she had an allergy or a cold all of a sudden. She had to rest for a few hours. By 4 pm she felt better. The patient was not tested for covid post vaccination. The patient did not receive any treatment. Outcome of the events was recovered on an unspecified date in Jan2021. Information on the Batch/Lot number has been requested.

Other Meds: Synthroid; Cytomel

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm